These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16146849)

  • 1. Mesenchymal stem cells in stem cell transplant recipients are damaged and remain of host origin.
    Wang J; Liu K; Lu DP
    Int J Hematol; 2005 Aug; 82(2):152-8. PubMed ID: 16146849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Origin of mesenchymal stem cells in bone marrow of patients after allogeneic stem cell transplantation].
    Wang J; Liu KY; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):322-6. PubMed ID: 16638207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expanding capacity of mesenchymal stem cells from patients after hematopoietic stem cell transplantation].
    Wang J; Liu KY; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):120-5. PubMed ID: 18315914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring the source of mesenchymal stem cells in patients after transplantation of mismatched-sex hematopoietic stem cells plus third-party cells.
    Wang J; Huang XJ; Xu LP; Liu DH; Chen H; Chen YH; Lai YY; Hou RQ; Qin XY; Liu KY
    Chin Med J (Engl); 2013 Nov; 126(22):4254-9. PubMed ID: 24238507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation.
    Rieger K; Marinets O; Fietz T; Körper S; Sommer D; Mücke C; Reufi B; Blau WI; Thiel E; Knauf WU
    Exp Hematol; 2005 May; 33(5):605-11. PubMed ID: 15850839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
    Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
    Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro.
    Isaikina Y; Kustanovich A; Svirnovski A
    Exp Oncol; 2006 Jun; 28(2):146-51. PubMed ID: 16837907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human mesenchymal stem cells are not of donor origin in patients with severe aplastic anemia who underwent sex-mismatched allogeneic bone marrow transplant.
    Stute N; Fehse B; Schröder J; Arps S; Adamietz P; Held KR; Zander AR
    J Hematother Stem Cell Res; 2002 Dec; 11(6):977-84. PubMed ID: 12590713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease.
    Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation.
    Cilloni D; Carlo-Stella C; Falzetti F; Sammarelli G; Regazzi E; Colla S; Rizzoli V; Aversa F; Martelli MF; Tabilio A
    Blood; 2000 Nov; 96(10):3637-43. PubMed ID: 11071665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
    Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A
    Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation.
    Fehse B; Chukhlovin A; Kühlcke K; Marinetz O; Vorwig O; Renges H; Krüger W; Zabelina T; Dudina O; Finckenstein FG; Kröger N; Kabisch H; Hochhaus A; Zander AR
    J Hematother Stem Cell Res; 2001 Jun; 10(3):419-25. PubMed ID: 11454317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo expansion of hematopoietic stem- and progenitor cells from cord blood in coculture with mesenchymal stroma cells from amnion, chorion, Wharton's jelly, amniotic fluid, cord blood, and bone marrow.
    Klein C; Strobel J; Zingsem J; Richter RH; Goecke TW; Beckmann MW; Eckstein R; Weisbach V
    Tissue Eng Part A; 2013 Dec; 19(23-24):2577-85. PubMed ID: 24308543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity.
    Copland IB; Qayed M; Garcia MA; Galipeau J; Waller EK
    Biol Blood Marrow Transplant; 2015 May; 21(5):934-40. PubMed ID: 25659882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and functional comparison of mesenchymal stem cells derived from the bone marrow of normal adults and patients with hematologic malignant diseases.
    Zhao ZG; Liang Y; Li K; Li WM; Li QB; Chen ZC; Zou P
    Stem Cells Dev; 2007 Aug; 16(4):637-48. PubMed ID: 17784837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
    Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
    Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation.
    Pozzi S; Lisini D; Podestà M; Bernardo ME; Sessarego N; Piaggio G; Cometa A; Giorgiani G; Mina T; Buldini B; Maccario R; Frassoni F; Locatelli F
    Exp Hematol; 2006 Jul; 34(7):934-42. PubMed ID: 16797421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of multipotent mesenchymal stromal cells used for acute graft-versus-host disease prophylaxis.
    Kuzmina LA; Petinati NA; Shipounova IN; Sats NV; Bigildeev AE; Zezina EA; Popova MD; Drize NJ; Parovichnikova EN; Savchenko VG
    Eur J Haematol; 2016 Apr; 96(4):425-34. PubMed ID: 26115424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases.
    Koç ON; Peters C; Aubourg P; Raghavan S; Dyhouse S; DeGasperi R; Kolodny EH; Yoseph YB; Gerson SL; Lazarus HM; Caplan AI; Watkins PA; Krivit W
    Exp Hematol; 1999 Nov; 27(11):1675-81. PubMed ID: 10560915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.